Rigel Pharmaceuticals Inc (RIGL)

3.24 -0.04  -1.22% NASDAQ Oct 22, 16:00 3.24 0.00  0.00% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All RIGL News

News

View All Events

Events

Date Type Description
11/05/2021 Earnings Results Q3 2021 Earnings Results
11/05/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
08/03/2021 Earnings Results Q2 2021 Earnings Results
08/03/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
05/18/2021 11:00 EST AGM 2020 Annual General Meeting
05/05/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
05/05/2021 Earnings Results Q1 2021 Earnings Results
03/02/2021 Earnings Results Q4 2020 Earnings Results
03/02/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 16:30 EST Earnings Calls Q3 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility to develop and market the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
  • URL: https://www.rigel.com
  • Investor Relations URL: https://www.rigel.com/investors
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 05, 2021
  • Last Earnings Release: Aug. 03, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
LCMGX Lord Abbett Micro Cap Growth C 1.59%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.